Badalona Major Depressive Disorder Database Study

AstraZeneca2,260 enrolled

Overview

A retrospective study using a data base of anonymized medical records. The purpose of the study is to examine the different therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care

Therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care: the Badalona database study

Study Type

OBSERVATIONAL

Enrollment

2,260

Conditions

Major Depressive Disorder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * An International Classification of Primary Care (ICPC-2) or DSM-IV-TR diagnosis for major depressive disorder (MDD) * At least 8 weeks of antidepressant treatment during the identification period of 01 January 2008 - 31 December 2009 * 18 months of enrollment with medical and pharmacy records after index episode date

Locations (1)

Research Site

Badalona, Spain

Outcomes

Primary Outcomes

Description of the antidepressant strategies switches

Number and type of treatment changes including combination, switch, or augmentation strategies.

Time frame: 18 months

Secondary Outcomes

Health care resource utilization

Time frame: 18 months

Health care costs

Time frame: 18 months

Hamilton Depression Rating Scale

Time frame: 18 months

Medication possession rate to evaluate adherence

Time frame: 18 months

Referral to psychiatrist office

Time frame: 18 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.